Metabolic Response
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment (NCT06563245) | Children's Cancer Group, China | 2024-09-25 |
Track Metabolic Response automatically
Every clearance here is in the API, with alerts when new ones post.